COVID-19 Hutch News
Search and Filter
Results per Page:
COVID-19 and what else? Researchers use metagenomics to find out
Pairing genome sequencing with cloud computing makes a speedy screen for coinfections, new viral threats
Essential workers illustrate the Heart of the Hutch
While buildings remain more than half empty, hundreds of people keep science going and campus running amid pandemic
Patients navigate cancer during COVID-19 pandemic
Scary waiting rooms, delayed scans and ‘virtual’ care: patients and providers try to dodge the collateral damage of coronavirus
Fred Hutch opens COVID-19 Clinical Research Center
Medical director outlines goals for the new facility that will host two treatment trials right away
Imperfect, widely used measures best option against COVID-19, argues Dr. Joshua Schiffer
We need tests, masks, treatments and vaccines to be widespread, not perfect, says infectious disease expert in New York Times editorial
Scientists discuss how the pandemic has changed their research
COVID-19 pushes Hutch panelists to apply expertise to tackle an epic scientific and public health challenge
CoVPN team leads campaign to ensure diversity in COVID-19 vaccine trials
Fred Hutch-based experts' extensive media efforts drive conversations and awareness about the importance of inclusive participation
'We still have so much work to do'
Hutch health disparities researcher speaks out on new national report decrying lack of equity in cancer care
'Everything we’ve been training for is happening now'
How early-career virologists dropped everything to seize the opportunity, and face the challenges, of studying the coronavirus
Stalled science, missed mates and virtual everything
Torn between science and safety concerns, young scientists navigate a new normal as they try to launch their careers
How COVID-19 has opened science
An urgent search for answers promotes a faster, freer exchange of ideas
Dr. Tom Lynch on the impact of COVID-19 on science
A conversation with the Fred Hutch president and director about open science, modeling, training and more
Public health’s pandemic pivot
With disease modeling, virtual events and a renewed focus on antiracism, Fred Hutch population scientists adapt their work to COVID-19
What happens if the coronavirus’s spikes mutate?
First-of-its-kind study explores how changes in the virus’s ‘lock picks’ could help or hinder its ability to sneak into our cells
Obliteride brings in $2M to spur cancer, COVID-19 research
Annual Fred Hutch fundraiser goes virtual and DIY; sets records for participation, creativity and global reach
Riding out the pandemic with Obliteride
Annual fundraiser goes DIY with creative workouts, global participation and Glow Orange week
The latest on how COVID-19 affects cancer patients
Hutch researchers share new data on mortality rates and racial disparities in treatment; launch statewide COVID-19 and cancer data repository
Improving apps to help cancer patients quit smoking
Fred Hutch cancer prevention researcher awarded $3.5M NCI grant to run randomized trial of smartphone health apps
Eating ‘the rainbow’ and other food tips for uncertain times
COVID-19 and cancer call for comfort food, but experts say baking with ‘whole-food ingredients’ and eating mostly plants will better support your immune system
Antibodies a hot topic in COVID-19 research
Hutch scientists tap their antibody expertise for new tests, treatments, vaccines